Eledon Pharmaceuticals Inc. (ELDN)
ELDN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.34
-4.10% on the day
Market cap
$190.2M
Micro cap
Revenue
No annual revenue filed since the period ending 2016-12-31
Net income
No annual revenue filed since the period ending 2016-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | ELDN on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2014 |
| SEC CIK | 0001404281 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
No annual revenue filed since the period ending 2016-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-05-01 |
| Latest annual report | 10-K | 2026-03-19 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-08-13 |
| Latest proxy | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 613 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TRDA | Entrada Therapeutics Inc. | $4.86 | -11.64% | $189.2M |
| UPB | Upstream Bio Inc. | $3.55 | -14.87% | $194.4M |
| LYEL | Lyell Immunopharma Inc. | $7.51 | -9.19% | $184.0M |
| SION | Sionna Therapeutics Inc. | $4.38 | -6.61% | $198.0M |
| RNAC | Cartesian Therapeutics Inc. | $6.57 | -6.01% | $198.8M |
| ORMP | Oramed Pharmaceuticals Inc. | $4.17 | -2.34% | $173.5M |
| NGEN | NervGen Pharma Corp. | $1.63 | -5.78% | $173.5M |
| PEPG | PepGen Inc. | $2.50 | +0.40% | $173.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier